TCM
GBT
Tekla Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-71,759
| Closed | -$3.96M | – | 211 |
|
|
2020
Q3 | $3.96M | Hold |
71,759
| – | – | 0.15% | 114 |
|
|
2020
Q2 | $4.53M | Sell |
71,759
-46,324
| -39% | -$2.92M | 0.17% | 108 |
|
|
2020
Q1 | $6.03M | Sell |
118,083
-29,085
| -20% | -$1.49M | 0.27% | 72 |
|
|
2019
Q4 | $11.7M | Buy |
147,168
+54,211
| +58% | +$4.31M | 0.44% | 50 |
|
|
2019
Q3 | $4.51M | Buy |
92,957
+25,441
| +38% | +$1.23M | 0.2% | 87 |
|
|
2019
Q2 | $3.55M | Sell |
67,516
-18,472
| -21% | -$972K | 0.14% | 109 |
|
|
2019
Q1 | $4.55M | Sell |
85,988
-7,936
| -8% | -$420K | 0.18% | 99 |
|
|
2018
Q4 | $3.86M | Sell |
93,924
-38,346
| -29% | -$1.57M | 0.17% | 98 |
|
|
2018
Q3 | $5.03M | Buy |
132,270
+72,880
| +123% | +$2.77M | 0.18% | 92 |
|
|
2018
Q2 | $2.68M | Sell |
59,390
-70,558
| -54% | -$3.19M | 0.1% | 123 |
|
|
2018
Q1 | $6.28M | Hold |
129,948
| – | – | 0.24% | 85 |
|
|
2017
Q4 | $5.11M | Buy |
129,948
+67,448
| +108% | +$2.65M | 0.2% | 91 |
|
|
2017
Q3 | $1.94M | Sell |
62,500
-62,500
| -50% | -$1.94M | 0.07% | 121 |
|
|
2017
Q2 | $3.42M | Sell |
125,000
-47,500
| -28% | -$1.3M | 0.13% | 94 |
|
|
2017
Q1 | $6.36M | Sell |
172,500
-208,800
| -55% | -$7.69M | 0.25% | 74 |
|
|
2016
Q4 | $5.51M | Buy |
381,300
+256,300
| +205% | +$3.7M | 0.23% | 75 |
|
|
2016
Q3 | $2.88M | Hold |
125,000
| – | – | 0.11% | 105 |
|
|
2016
Q2 | $2.07M | Buy |
+125,000
| New | +$2.07M | 0.08% | 116 |
|